Author:
Contreras Vera Sofía Lorena,Laube Dr. Gerardo
Abstract
Introduction: Sexually transmitted infections (STDs) constitute a group of very frequent diseases worldwide and an important public health problem. Currently, the positivity of new cases is alarming, which is why it is necessary to renew the preventive strategies and awareness of STDs together with pre-exposure prophylaxis (PrEP) that has proven to be not only effective but also profitable and safe. Objectives: The objective of this Systematic Review of the literature is to evaluate, through the study of scientific publications, the impact, safety, efficacy and controversies that arise from patients with sexually transmitted diseases who are under PrEP therapy for HIV and identify the barriers that exist in the adequate information on the part of the population. Materials and methods: In this systematic review of the literature, research articles published to date on various platforms available on the Internet such as PubMed, Google Schoolar, MedLine, ResearchGate are analyzed in order to obtain reliable data that relationships of sexually transmitted diseases in people on PrEP therapy
Publisher
Salud, Ciencia y Tecnologia
Reference50 articles.
1. Moreno-Ribera N, Fuertes-de Vega I, Blanco-Arévalo JL, Bosch-Mestres J, GonzálezCordón A, Estrach-Panella T, et al. Infecciones de transmisión sexual: experiencia de una consulta multidisciplinar en un hospital terciario (2010-2013). Actas Dermo-Sifiliográficas. abril de 2016;107(3):235-41.
2. InformeVIH_SIDA_2016.pdf [Internet]. [citado 26 de diciembre de 2022]. Disponible en: https://www.sanidad.gob.es/ciudadanos/enfLesiones/enfTransmisibles/sida/vigilancia/InformeV IH_SIDA_2016.pdf
3. rd592_1993.pdf [Internet]. [citado 26 de diciembre de 2022]. Disponible en: http://www.mscbs.es/va/ciudadanos/enfLesiones/enfTransmisibles/sida/docs/rd592_1993.pdf
4. McCormack S, Dunn DT, Desai M, Dolling DI, Gafos M, Gilson R, et al. Preexposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic openlabel randomised trial. The Lancet. enero de 2016;387(10013):53-60.
5. Molina JM, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I, et al. OnDemand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection. N Engl J Med. 3 de diciembre de 2015;373(23):2237-46.